Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition, contributing significantly to global morbidity and mortality. Traditional diagnostic tools are effective in diagnosing COPD. However, these tools demand specialized equipment and expertise. Advances in artificial intelligence (AI) provide a platform for enhancing COPD diagnosis by leveraging diverse data modalities. The existing reviews primarily focus on single modalities and lack information on interpretability and explainability. Thus, this review intends to synthesize the AI-powered frameworks for COPD identification, focusing on data modalities, methodological innovation, evaluation strategies, and reporting limitations and potential biases. By adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic search was conducted across multiple repositories. From an initial pool of 1978 records, 22 studies were included in this review. The included studies demonstrated exceptional performance in specific settings. Most studies were retrospective and limited in diversity, lacking generalizability and external or prospective validation. This review presents a roadmap for advancing AI-assisted COPD detection. By highlighting the strengths and limitations of existing studies, it supports the development of future research. Future studies can utilize the findings to build models using prospective, multicenter, and multi-ethnic validations, ensuring generalizability and fairness.
BACKGROUND: Down syndrome (DS) is one of the most prevalent chromosomal abnormalities affecting global healthcare. Recent advances in artificial intelligence (AI) and machine learning (ML) have enhanced DS diagnostic accuracy. However, there is a lack of thorough evaluations analyzing the overall impact and effectiveness of AI-based DS diagnostic approaches. OBJECTIVES: This review intends to identify methodologies and technologies used in AI-driven DS diagnostics. It evaluates the performance of AI models in terms of standard evaluation metrics, highlighting their strengths and limitations. METHODOLOGY: In order to ensure transparency and rigor, the authors followed the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. They extracted 1175 articles from major academic databases. By leveraging inclusion and exclusion criteria, a final set of 25 articles was selected. OUTCOMES: The findings revealed significant advancements in AI-powered DS diagnostics across diverse data modalities. The modalities, including facial images, ultrasound scans, and genetic data, demonstrated strong potential for early DS diagnosis. Despite these advancements, this review outlined the limitations of AI approaches. Small and imbalanced datasets reduce the generalizability of the AI models. The authors present actionable strategies to enhance the clinical adoptions of these models.
Down syndromeartificial intelligencemachine learningprenatal diagnosis
The incidence of suicide, self-harm, and mental crises among teenagers is rising, presenting significant global public health issues. Conventional clinical risk evaluations have inadequate predictive accuracy, often overlooking high-risk adolescents. Machine learning models employing electronic health records provide an innovative method for predicting mental health crises through the integration of intricate clinical data patterns. Hence, this review aims to comprehensively examine and synthesize information about machine learning models created using electronic health record data for predicting suicide attempts, self-harm, or mental hospitalization in teenagers. Adhering to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) principles, we executed an exhaustive search across six databases (2000-2025) for peer-reviewed research utilizing machine learning algorithms on electronic health record data to predict adolescent mental health crises. The inclusion criteria emphasized structured or unstructured electronic health record inputs, teenage cohorts (ages 10-20), and performance indicators like area under the curve (AUC), sensitivity, or specificity. The Prediction Model Risk of Bias Assessment Tool (PROBAST) was utilized to evaluate the risk of bias. Our search yielded five studies (2019-2024) that satisfied the inclusion criteria. All studies were retrospective cohorts conducted in high-income nations. Structured electronic health record data (e.g., diagnoses, prescriptions) were frequently utilized; two studies included natural language processing. Machine learning models demonstrated moderate to high discrimination (AUC 0.68-0.88), exhibiting optimal performance in short-term suicide prediction with hybrid data inputs. All investigations, however, exhibited a significant risk of bias in the analysis domain owing to insufficient external validation and absent calibration data. The positive predictive values consistently remained modest across all models. Overall, machine learning models demonstrate potential for enhancing adolescent suicide risk classification utilizing electronic health record data, surpassing numerous traditional instruments. Nonetheless, issues of generalizability, ethical constraints, and implementation obstacles remain. Thorough validation, calibration, and equity assessments are necessary prior to incorporation into clinical practice.
adolescent mental healthsuicide risk predictionself-harmelectronic health records
Sepsis is a life-threatening condition, and early recognition in the emergency department (ED) is crucial for reducing mortality. However, traditional ED sepsis screening tools (e.g., Systemic Inflammatory Response Syndrome (SIRS) and quick Sequential Organ Failure Assessment (qSOFA)) often lack sensitivity for early detection. Machine learning (ML)-based early warning systems have been proposed to address this gap by analyzing complex clinical data in real time. To address this, we systematically reviewed studies (2015-2025) assessing ML-based sepsis warning systems in adult EDs. Databases searched included PubMed, Embase, Scopus, and Web of Science. Included studies reported diagnostic performance and/or clinical outcomes. Overall, a total of 11 studies (primarily retrospective, with a few prospective) were included. ML models using vital signs, laboratory results, and electronic health record (EHR) data demonstrated high discrimination for sepsis, with area under the receiver operating characteristic curve (AUROC) values often exceeding 0.80, and outperformed traditional scoring tools. Many provided earlier warnings, often two to four hours before sepsis was clinically recognized. Implementation studies showed that ML-based alerts expedited treatment; one multi-center system reduced time to antibiotics by ~1.8 hours when alerts were promptly addressed. Some reports noted reduced organ failure and mortality. However, evidence of improved patient outcomes remains inconsistent, likely due to study heterogeneity and limited prospective validation. ML-based early warning systems show strong potential for improving sepsis recognition and treatment in EDs. Further multi-center trials are needed to confirm their impact on outcomes and guide safe implementation.
sepsisearly warning systemsmachine learningemergency department
Plastic and reconstructive surgery increasingly depends on data-driven instruments to improve clinical decision-making. Machine learning (ML), through its capacity to analyze intricate, high-dimensional data, presents novel prospects for forecasting surgical outcomes with enhanced accuracy compared to traditional statistical models. This systematic study evaluates the extent, efficacy, and methodological rigor of ML applications in plastic and reconstructive surgery, encompassing burn treatment, microsurgical reconstruction, and breast surgery. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 standards, we searched four main databases for research published between January 2015 and March 2025. Eligible papers used ML models to predict clinical outcomes in plastic or reconstructive surgery and provided quantifiable performance indicators. Data were retrieved using the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies (CHARMS) and Prediction Model Risk of Bias Assessment Tool (PROBAST) frameworks, then synthesized narratively. We included eleven studies that had more than 34,000 patients. Random forests, neural networks, and gradient boosting have emerged as the most prevalent and highest-performing models, with several attaining AUCs exceeding 0.90. Notwithstanding encouraging outcomes, the majority of research depended on internal validation, with only one performing external validation. Calibration reporting and data transparency were constrained. The majority of studies exhibited a high or moderate risk of bias. In summary, ML models provide significant prediction accuracy in plastic surgery; yet, they are limited by methodological deficiencies that impede clinical implementation. Future initiatives must prioritize external validation, repeatability, and ethical execution to facilitate the safe and successful incorporation into surgical practice.
Autism spectrum disorder (ASD) is a diverse neurodevelopmental condition with a significant genetic basis. Machine learning (ML) and deep learning (DL) models are emerging as powerful tools for identifying potential ASD risk genes and biomarkers to improve diagnostic accuracy. This narrative systematic review synthesizes evidence on the use of ML and DL models for ASD prediction and diagnosis, focusing on studies that utilized genetic variants and biomarkers. We conducted a systematic search across six databases [Web of Science, PubMed, Science Direct, Semantic Scholar, Institute of Electrical and Electronics Engineers (IEEE Xplore), and Association for Computing Machinery Digital Library (ACM-DL)] for articles published between 2009 and 2024, yielding 483 initial records. Multiple inclusion criteria were applied, and only peer-reviewed articles that used artificial intelligence, ML, or DL to predict ASD based on genetic biomarkers were included. After deduplication and applying inclusion and exclusion criteria, 14 studies were included in this review. These studies focused on genetic variants based on whole-genome sequencing, whole-exome sequencing, RNA sequencing, single-nucleus RNA sequencing, mRNA expression, long non-coding RNA, or single nucleotide polymorphism data. Our findings indicate that various ML models achieved robust performance, while DL architectures such as DeepASDPred outperformed ML models, with an accuracy of 93.8%. Most of the studies used datasets such as the Simons Foundation Autism Research Initiative (SFARI), the Simons Simplex Collection (SSC), the Autism Genetic Resource Exchange (AGRE), Atlas of the Developing Human Brain (BrainSpan), and the Simons Foundation Powering Autism Research for Knowledge (SPARK). The reviewed studies demonstrate that ML can help identify genetic risk factors and biomarkers that contribute to ASD. However, challenges remain, including data heterogeneity, small sample sizes, and the need for greater model interpretability. Addressing these challenges is crucial for translating ML models into clinically useful tools. In conclusion, DL substantially enhances ASD prediction, leveraging genetic data to identify novel candidate genes and support biological discovery of cell type-specific gene expression and roles of non-coding mutations in ASD.
International Journal of Molecular Sciences · مجلد 25 (12) · 6422-6422
The process of identification and management of neurological disorder conditions faces challenges, prompting the investigation of novel methods in order to improve diagnostic accuracy. In this study, we conducted a systematic literature review to identify the significance of genetics- and molecular-pathway-based machine learning (ML) models in treating neurological disorder conditions. According to the study's objectives, search strategies were developed to extract the research studies using digital libraries. We followed rigorous study selection criteria. A total of 24 studies met the inclusion criteria and were included in the review. We classified the studies based on neurological disorders. The included studies highlighted multiple methodologies and exceptional results in treating neurological disorders. The study findings underscore the potential of the existing models, presenting personalized interventions based on the individual's conditions. The findings offer better-performing approaches that handle genetics and molecular data to generate effective outcomes. Moreover, we discuss the future research directions and challenges, emphasizing the demand for generalizing existing models in real-world clinical settings. This study contributes to advancing knowledge in the field of diagnosis and management of neurological disorders.
Neuro-developmental delay (NDD) is when a child's reflexes and nervous system are underdeveloped or immature at a given stage of child development. Neurodevelopmental delays account for delayed skill development surrounding speech, social, emotional, behavioral, motor, and cognitive delays. NDD might affect the child's psychological and physical well-being, resulting in chronic disease and disabilities throughout adulthood. This review sought to investigate the implication of early diagnosis and intervention of NDD in children. In this regard, this research opted for a systematic meta-analysis that used keywords and Boolean operators to search through main databases, including the Web of Science, JStor, PsychINFO, Science Direct, Cochrane, Scopus, and ASSIA. The result identified that telehealth interventions improved the management of NDD in children. Also, the Early Start Denver Model (ESDM) model was determined to improve the quality of life for NDD children. Another model was LEAP (Learning Experience and Alternative Program for Preschoolers and Their Parents) and Leap (Learning, engaging, and Playing), which improved behavioral, education, and social interventions in NDD children. The study identified that technology could revolutionize NDD interventions in children, possibly improving the quality of life. The parent-children relationship was shown to enhance the management of this condition; thus, it is recommended as one of the best ways to intervene in the management of NDD. Most importantly, the integration of machine learning algorithms and technology can create models; while this may not be significant in the treatment of childhood NDD but instead might be ideal in improving the quality of life for NDD children. Moreover, their social and communication skills along with academic achievements will improve. The study proposes further research in order to understand the different types of NDDs and their intervention strategies to help the researchers identify the most accurate models to improve the conditions and support the parents and guardians in the management.
The genesis of cancer is a precisely organized process in which normal cells undergo genetic alterations that cause the cells to multiply abnormally, colonize, and metastasize to other organs such as the liver, lungs, colon, and brain. Potential drugs that could modify these carcinogenic pathways are the ones that will be used in clinical trials as anti-cancer drugs. Resveratrol (RES) is a polyphenolic natural antitoxin that has been utilized for the treatment of several diseases, owing to its ability to scavenge free radicals, control the expression and activity of antioxidant enzymes, and have effects on inflammation, cancer, aging, diabetes, and cardioprotection. Although RES has a variety of pharmacological uses and shows promising applications in natural medicine, its unpredictable pharmacokinetics compromise its therapeutic efficacy and prevent its use in clinical settings. RES has been encapsulated into various nanocarriers, such as liposomes, polymeric nanoparticles, lipidic nanocarriers, and inorganic nanoparticles, to address these issues. These nanocarriers can modulate drug release, increase bioavailability, and reach therapeutically relevant plasma concentrations. Studies on resveratrol-rich nano-formulations in various cancer types are compiled in the current article. Studies relating to enhanced drug stability, increased therapeutic potential in terms of pharmacokinetics and pharmacodynamics, and reduced toxicity to cells and tissues are the main topics of this research. To keep the readers informed about the current state of resveratrol nano-formulations from an industrial perspective, some recent and significant patent literature has also been provided. Here, the prospects for nano-formulations are briefly discussed, along with machine learning and pharmacometrics methods for resolving resveratrol's pharmacokinetic concerns.
Artificial intelligence (AI) has been described as one of the extremely effective and promising scientific tools available to mankind. AI and its associated innovations are becoming more popular in industry and culture, and they are starting to show up in healthcare. Numerous facets of healthcare, as well as regulatory procedures within providers, payers, and pharmaceutical companies, may be transformed by these innovations. As a result, the purpose of this review is to identify the potential machine learning applications in the field of infectious diseases and the general healthcare system. The literature on this topic was extracted from various databases, such as Google, Google Scholar, Pubmed, Scopus, and Web of Science. The articles having important information were selected for this review. The most challenging task for AI in such healthcare sectors is to sustain its adoption in daily clinical practice, regardless of whether the programs are scalable enough to be useful. Based on the summarized data, it has been concluded that AI can assist healthcare staff in expanding their knowledge, allowing them to spend more time providing direct patient care and reducing weariness. Overall, we might conclude that the future of "conventional medicine" is closer than we realize, with patients seeing a computer first and subsequently a doctor.
artificial intelligence in healthcaremachine learninginfectious diseasesdisease prevention